Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.

Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug resistance.

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

The field of neurodegeneration is witnessing rapid advancements thanks to the integration of multi-omics technologies alongside sophisticated artificial ...

The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...

This issue of the journal features a Series of three papers on artificial intelligence (AI) in infectious diseases. The Series, led by Anna Odone (University of Pavia, Italy) and published online in ...

Identifying future trends and technologies continues to be a “million-dollar question,” said Raffaella Cornaggia, most recently CEO of Kering Beauté at Fortune CEO Forum. Every year, the Fortune CEO ...

Students with disabilities may be missing out on valuable assistive technology, a new report finds, due to limited awareness among school staff and other issues. The Individuals with Disabilities ...

Lymph nodes are key sites of adaptive immune responses, yet how immune cells coordinate their activities in space and time remains poorly understood. We combined high-resolution spatial ...

For software as a service companies, success often seems straightforward: Build a useful product, price it competitively, acquire customers, repeat. However, in a subscription model, the sale is just ...

Food security, climate change, global health: Agriculture is where the world’s most serious challenges collide. As the global population grows, farms must produce 60 percent more food by 2050, but ...